Product Information
VYFEMLA 0.4 MG-0.035 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3471 per EA under NDC 68180087573. Its NADAC has been published 285 times since Mar 10, 2021.
FDA first approved this application on Sep 26, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180087573
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201886FDA Approved
9/26/2013
TE Code
AB
On Market Since
11/4/2020
Price Statistics
The NADAC for VYFEMLA 0.4 MG-0.035 MG TABLET has been published 285 times since Mar 10, 2021, and over the history we have for it it has declined 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3471 per EA |
|---|---|
| All-time high | $0.6417 (Oct 13, 2021) |
| All-time low | $0.2566 (Nov 20, 2024) |
| 52-week high | $0.3471 |
| 52-week low | $0.2982 |
| Median price | $0.4098 |
| Average price | $0.4231 |
| Largest weekly change | +55.5% (May 19, 2021) |
| Weeks tracked | 285 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VYFEMLA 0.4 MG-0.035 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VYFEMLA 0.4 MG-0.035 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.3471 per EA (NDC 68180087573), effective Aug 19, 2026.
How has the price of VYFEMLA 0.4 MG-0.035 MG TABLET changed over time?
Over the history we have for it, the NADAC for VYFEMLA 0.4 MG-0.035 MG TABLET has declined 25.9%. It has been tracked across 285 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for VYFEMLA 0.4 MG-0.035 MG TABLET?
Since Mar 10, 2021, the NADAC for VYFEMLA 0.4 MG-0.035 MG TABLET has ranged from a low of $0.2566 (Nov 20, 2024) to a high of $0.6417 (Oct 13, 2021), with a median of $0.4098 per EA.
Are there cheaper alternatives to VYFEMLA 0.4 MG-0.035 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALYACEN 1-35 28 TABLET, is $0.2116 per EA — about 39% below VYFEMLA 0.4 MG-0.035 MG TABLET.
Who manufactures VYFEMLA 0.4 MG-0.035 MG TABLET?
VYFEMLA 0.4 MG-0.035 MG TABLET (NDC 68180087573) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.